Navigation Links
Rigel Announces Participation at Two Investor Conferences
Date:2/23/2012

SOUTH SAN FRANCISCO, Calif., Feb. 23, 2012 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, chairman and chief executive officer, and Ryan Maynard, executive vice president and chief financial officer of Rigel, will participate at two upcoming investor conferences. Details of the events are as follows:

(Logo:  http://photos.prnewswire.com/prnh/20030226/RIGLLOGO)

Citi 2012 Global Health Care Conference
Date: Monday, February 27 at 1:30 p.m. ET
Location: New York, NY
Presenter – Ryan Maynard

32nd Annual Cowen and Company Health Care Conference
Date: Monday, March 5 at 1:30 p.m. ET
Location: Boston, MA
Presenter – James M. Gower

Both events will be webcast live and can be accessed at www.rigel.com.  Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software download that may be necessary.

About Rigel (www.rigel.com)

Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. Rigel's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market its product candidates. Current product development programs include fostamatinib, an oral SYK inhibitor that is in Phase 3 clinical trials for rheumatoid arthritis, R343, an inhaled SYK inhibitor that has completed Phase 1 clinical trials for asthma, R548, an oral JAK3 inhibitor for the treatment of transplant rejection and other immune disorders, and R333, a topical JAK/SYK inhibitor for the treatment of discoid lupus.

Contact: Ryan Maynard
Phone: 650.624.1284
Email: invrel@rigel.com


'/>"/>
SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Rigel Announces Initiation of Clinical Trials in Two Immunology Programs
2. Rigel to Present at Oppenheimer Annual Healthcare Conference
3. Rigel Announces Third Quarter 2011 Financial Results
4. Rigel to Present at Two Upcoming Investor Conferences
5. Rigel to Present at Wells Fargo Securities Healthcare Conference
6. Rigel to Present at Jefferies Global Healthcare Conference
7. Rigel Announces Pricing of Public Offering of Common Stock
8. Rigel Announces Proposed Public Offering of Common Stock
9. Rigel to Present at Bank of America Merrill Lynch Health Care Conference
10. Rigel Announces First Quarter Financial Results
11. Rigel Announces Fourth Quarter and Year End 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2017)... 9, 2017  Semler Scientific, Inc. (OTCQB: SMLR), ... to improve the clinical effectiveness and efficiency of ... first quarter ended March 31, 2017. ... customers to identify when preventive care options are ... like heart attacks or strokes occur," said ...
(Date:5/6/2017)... , May 5, 2017  May is Stroke ... one of the most important methods to prevent a ... the Centers for Disease Control and Prevention, undetected and ... 1 Omron, the global leader in personal heart ... the elimination of heart attack and stroke and is ...
(Date:5/4/2017)... SAN DIEGO , May 4, 2017 /PRNewswire/ ... is demonstrating its wireless, handheld ultrasound scanners this ... Gynecologists Annual Scientific Meeting (ACOG) in ... 2017. "Clarius is the perfect ... fetal growth and heart rate, and evaluate pregnancy-related ...
Breaking Medicine Technology:
(Date:5/23/2017)... ... May 23, 2017 , ... i2i Population Health, ... in KLAS category winner, has named Daniel P. Bullington as chief technology officer. ... technology platform and product offerings,” says Justin Neece, president. “Daniel is an excellent ...
(Date:5/23/2017)... Beach, CA (PRWEB) , ... May 23, 2017 , ... ... Partners was honored to serve earlier this month as a Guest Speaker and Contributor ... the British Royal Family and Common Purpose. , Walter Schindler and ...
(Date:5/23/2017)... ... May 23, 2017 , ... By all indications, and ... Sonoma County. While officials call for diligence, asking homeowners to scout for any open ... health concerns. Along with the annoying buzz of mosquitos is the buzz associated with ...
(Date:5/23/2017)... New York, New York (PRWEB) , ... May ... ... partnership with NextGen LifeLabs, a leading equipment provider in the modern ART laboratory, ... Embryology Training Institute in Ft. Lauderdale, Florida. , NextGen LifeLabs, a MedTech ...
(Date:5/23/2017)... ... ... New patients from Charleston, SC, are now welcome to receive a full mouth ... or without a referral. A full mouth reconstruction can transform the appearance of the ... SC. Those who suffer from gum disease, misaligned teeth or jaw pain can also ...
Breaking Medicine News(10 mins):